FAKTOR-OPTIONSSCHEIN - INCYTE CO. Share Price

DE000SN712R8

Market Closed - Börse Stuttgart 16:35:43 17/05/2024 BST
0.22 ^EUR	0.00%

Current month	+69.23%
1 month	+29.41%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	05-15
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	05-14	BU
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	05-13	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	05-13	MT

More news

Quotes 5-day view

Date	Price	Change
17/05/24	0.22	0.00%
16/05/24	0.22	0.00%
15/05/24	0.22	-4.35%
14/05/24	0.23	0.00%
13/05/24	0.23	+43.75%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 04:35 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SN712R
ISIN	DE000SN712R8
Date issued	11/08/2022
Strike	73.76 $
Maturity	Unlimited
Parity	1 : 1
Emission price	10.18 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	15.31 €
Lowest since issue	0.12 €
Spread	0.01 €
Spread %	4.17%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.1 USD

Average target price

73.35 USD

Spread / Average Target

+28.46%

Consensus